Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

Open access
Raverdy, Violeta, Tavaglione, Federica, Chatelain, Estelle, Lassailly, Guillaume, De Vincentis, Antonio, Vespasiani-Gentilucci, Umberto, Qadri, Sami F., Caiazzo, Robert, Verkindt, Helene, Saponaro, Chiara, Kerr-Conte, Julie, Baud, Gregory, Marciniak, Camille, Chetboun, Mikael, Oukhouya-Daoud, Naima, Blanck, Samuel, Vandel, Jimmy, Olsson, Lisa, Chakaroun, Rima, Gnemmi, Viviane, Leteurtre, Emmanuelle, Lefebvre, Philippe, Haas, Joel T., Yki-Järvinen, Hannele, Francque, Sven, Staels, Bart, Le Roux, Carel W., Tremaroli, Valentina, Mathurin, Philippe, Marot, Guillemette, Romeo, Stefano, Pattou, François·2024·Nature Medicine

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) exhibits considerable variability in clinical outcomes. Identifying specific phenotypic profiles within MASLD is essential for developing targeted therapeutic strategies. Here we investigated the heterogeneity of MASLD using partitioning around medoids clustering based on six simple clinical variables in a cohort of 1,389 individuals living with obesity. The identified clusters were applied across three independent MASLD cohorts with liver biopsy (totaling 1,099 participants), and in the UK Biobank to assess the incidence of chronic liver disease, cardiovascular disease and type 2 diabetes. Results unveiled two distinct types of MASLD associated with steatohepatitis on histology and liver imaging. The first cluster, liver-specific, was genetically linked and showed rapid progression of chronic liver disease but limited risk of cardiovascular disease. The second cluster, cardiometabolic, was primarily associated with dysglycemia and high levels of triglycerides, leading to a similar incidence of chronic liver disease but a higher risk of cardiovascular disease and type 2 diabetes. Analyses of samples from 831 individuals with available liver transcriptomics and 1,322 with available plasma metabolomics highlighted that these two types of MASLD exhibited distinct liver transcriptomic profiles and plasma metabolomic signatures, respectively. In conclusion, these data provide preliminary evidence of the existence of two distinct types of clinically relevant MASLD with similar liver phenotypes at baseline, but each with specific underlying biological profiles and different clinical trajectories, suggesting the need for tailored therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-024-03283-1

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Metadata

Authors
Raverdy, V., Tavaglione, F., Chatelain, E., Lassailly, G., De Vincentis, A., Vespasiani-Gentilucci, U., Qadri, S. F., Caiazzo, R., Verkindt, H., Saponaro, C., Kerr-Conte, J., Baud, G., Marciniak, C., Chetboun, M., Oukhouya-Daoud, N., Blanck, S., Vandel, J., Olsson, L., Chakaroun, R., Gnemmi, V., Leteurtre, E., Lefebvre, P., Haas, J. T., Yki-Järvinen, H., Francque, S., Staels, B., Le Roux, C. W., Tremaroli, V., Mathurin, P., Marot, G., Romeo, S., & Pattou, F.
Venue
Nature Medicine
Published
2024-12
Volume
30
Issue
12
Pages
3624-3633
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4405194816
Cited by
169
References
21
FWCI
44.19
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease. https://app.cochat.ai/papers/10.1038/s41591-024-03283-1
The paper
Raverdy, V., Tavaglione, F., Chatelain, E., Lassailly, G., De Vincentis, A., Vespasiani-Gentilucci, U., Qadri, S. F., Caiazzo, R., Verkindt, H., Saponaro, C., Kerr-Conte, J., Baud, G., Marciniak, C., Chetboun, M., Oukhouya-Daoud, N., Blanck, S., Vandel, J., Olsson, L., Chakaroun, R., . . . Pattou, F. (2024). Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease. Nature Medicine. https://doi.org/10.1038/s41591-024-03283-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.